Isolated Atrial Fibrillation Ablation in Patients With Isolated Atrial Flutter (TripleA)

NCT02051621 NA UNKNOWN

Ablation of the cavotricuspid isthmus (CTI) in the right atrium is currently the therapy of choice for the treatment of typical atrial flutter (3,4). It is a curative approach and has a high success rate (5). It has been recognized that patients with typical atrial flutter often complain of atrial fibrillation (1,2). Current clinical and experimental studies confirm the close relationship between atrial flutter (AFL) and atrial fibrillation (AF) and raise a question, if both arrhythmias are different forms of a common electrical phenomenon with atrial fibrillation being the underlying clinical problem (6).

Details

Lead sponsor	University of Rostock
Phase	NA
Status	UNKNOWN
Enrolment	100
Start date	2010-08
Completion	2017-08

Conditions

• Atrial Fibrillation
• Atrial Flutter

Interventions

• Antiarrhythmic drug
• Cavo-tricuspid-isthmus-ablation
• Pulmonary vein isolation

Primary outcomes

• Number or patients with a recurrence of any atrial arrhythmia — 2 years
  Number (percentage) of patients with any atrial arrhythmia lasting longer than 30 s after ablation assessed by implantable loop recorder or 7-day-holter-ECG: AFL after AF ablation compared to the AFL ablation group and AF in both ablation groups

Countries

Germany